Anticancer activity and tolerance of treatments received beyond progression in men treated upfront with androgen deprivation therapy with or without docetaxel for metastatic castration-naive prostate cancer in the GETUG-AFU 15 phase 3 trial
Nom du journal : Eur Urol
Année : 2018
Volume : 73
Page de départ : 696
Page de fin : 703